Cannabis Extraction Market Size, Share, Growth, and Industry Analysis, By Type (Solvent-less Extraction,Sub/Supercritical CO2 Extraction,Ethanol Extraction,Hydrocarbon Extraction,OthersS), By Application (Recreational,Medical), Regional Insights and Forecast to 2035

Cannabis Extraction Market Overview

The global Cannabis Extraction Market is forecast to expand from USD 4865.79 million in 2026 to USD 5876.42 million in 2027, and is expected to reach USD 26594.04 million by 2035, growing at a CAGR of 20.77% over the forecast period.

The market is witnessing robust growth driven by the increasing demand for cannabinoids in pharmaceutical, cosmetic, and food & beverage applications. In 2024 alone, North America accounted for 45% of global cannabis extraction operations, while Europe represented 22%, reflecting the expansion of legalized medical cannabis programs. Extraction technologies such as CO2 and ethanol extraction dominate 60% of market adoption, with over 8,200 extraction facilities operating worldwide by 2025. The surge in consumer preference for high-purity cannabinoid concentrates has amplified the focus on advanced extraction processes that maintain compound integrity.

In the USA, the market is highly concentrated with over 3,400 licensed cannabis extraction facilities operating as of 2025. States like California, Colorado, and Oregon contribute to 65% of national production, with California alone processing 1,800 metric tons of cannabis annually. The country accounts for more than 50% of global cannabis oil consumption, driven by recreational and medical use. Key technologies include supercritical CO2 extraction, which represents 48% of all extraction methods, and solvent-less extraction, which covers 25% of operations. The focus on product innovation, regulatory compliance, and increasing adoption by pharmaceutical companies positions the U.S. market for sustained expansion.

Looking ahead, global market players are expected to invest in automation and scalable extraction units. By 2030, over 12,000 extraction units are projected worldwide, with a significant share in North America and Europe. Advanced extraction methods, such as ultrasonic and hybrid solvent techniques, are gaining traction, opening new avenues for high-value cannabis-derived products. Market opportunities in cosmetics, nutraceuticals, and functional foods are expected to drive adoption, while evolving government policies continue to shape industry dynamics.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising medical cannabis consumption accounts for 55% adoption, recreational use contributes 30%, and industrial hemp derivatives represent 15% of the market.
• Major Market Restraint: Strict regulations impact 42% of production, high operational costs affect 35%, and technology limitations account for 23% of market challenges.
• Emerging Trends: CO2 extraction adoption is 50%, solvent-less extraction growth is 28%, and hybrid technology integration covers 22% of new market activities.
• Regional Leadership: North America leads with 45%, Europe 22%, Asia-Pacific 18%, and the rest of the world accounts for 15%.
• Competitive Landscape: Top 10 players control 70%, mid-tier companies represent 20%, and small-scale operations constitute 10% of market share.
• Market Segmentation: By type, CO2 extraction 48%, solvent-less 25%, other methods 27%; by application, medical 55%, recreational 45%.
• Recent Development: Technology upgrades 40%, new facility launches 30%, regulatory approvals 20%, partnerships 5%, and mergers & acquisitions 5%.

Cannabis Extraction Market Trends

The cannabis extraction market is witnessing significant transformation due to increasing technological innovations and regulatory reforms. In 2024, 62% of extraction facilities globally adopted supercritical CO2 methods, while solvent-less extraction grew by 28% in the same period. Innovations such as ultrasonic-assisted extraction are being implemented in 12% of advanced laboratories. Market demand for high-purity cannabinoids is rising, with medical applications accounting for 55% of product usage and recreational for 45%. In North America, over 3,400 licensed extraction units contributed to processing 2,100 metric tons of cannabis in 2025, emphasizing growth in high-value extracts. Europe saw over 1,200 facilities operational by 2025, while Asia-Pacific is projected to increase from 300 facilities in 2024 to 800 by 2030.

Cannabis Extraction Market Dynamics

The cannabis extraction market is heavily influenced by technological advancements, regulatory frameworks, and rising consumer demand for cannabinoid-rich products. In 2024, over 3,400 extraction facilities were operational in the United States, representing 50% of the global capacity, while Europe accounted for 22% with 1,200 licensed units. North American medical cannabis consumption alone reached 1,050 metric tons in 2025. Supercritical CO2 extraction accounted for 48% of total extraction methods globally, while ethanol extraction covered 20%, reflecting a trend toward high-purity, solvent-free concentrates. The growth of edibles and nutraceuticals drove 35% of the demand for extracted cannabinoids, while cosmetics and skincare applications contributed 18% in 2025.

DRIVER

"Increasing adoption of advanced extraction technologies is driving the Cannabis Extraction market."

Cannabis Extraction is witnessing rapid growth due to the rising demand for high-purity cannabinoid products. In 2025, supercritical CO2 extraction accounted for 48% of total global extraction methods, while solvent-less methods made up 25%. The medical cannabis sector contributed to 55% of extraction demand, whereas recreational usage drove 30%, and industrial hemp applications represented 15%. Over 8,200 extraction facilities are projected to operate globally by 2030, with North America leading at 45% of the market share. Technological innovations such as hybrid solvent systems and ultrasonic-assisted extraction have improved efficiency and yield, adopted by over 12% of facilities worldwide.

RESTRAINT

"Regulatory barriers and high operational costs limit Cannabis Extraction market growth."

Cannabis Extraction faces challenges due to stringent government regulations and compliance requirements, which impact 42% of production facilities globally. Operational costs, including energy-intensive extraction methods and solvent management, restrict 35% of small and medium-scale players. Limited access to skilled labor and certified laboratories affects 15% of emerging markets in Asia-Pacific and the Middle East. Legal restrictions in countries with partial cannabis legalization slow market expansion, accounting for 8% of regional delays. Additionally, fluctuating quality of raw cannabis material impacts 20% of extraction operations, particularly in regions relying on outdoor cultivation.

OPPORTUNITY

"Expansion into high-value applications presents significant growth potential in Cannabis Extraction."

Cannabis Extraction is poised for rapid expansion due to emerging applications in pharmaceuticals, cosmetics, functional foods, and nutraceuticals. Medical usage represents 55% of total cannabinoid extraction, with over 1,050 metric tons processed in North America in 2025. Cosmetic applications accounted for 18% of product consumption, while edibles and beverages contributed 35% to the overall demand for extracts. The Asia-Pacific region is expected to increase extraction facilities from 300 in 2024 to 800 by 2030, driven by legalization initiatives in Thailand, South Korea, and Australia. Technological advancements, including hybrid solvent and ultrasonic-assisted extraction, are being adopted by 12% of global facilities, offering higher yields and purity levels.

CHALLENGE

"Fluctuating raw material quality and market fragmentation challenge Cannabis Extraction market players."

Cannabis Extraction faces operational challenges due to inconsistent quality of raw cannabis biomass, affecting 20% of global production. Small and medium-scale facilities experience limited access to certified labs, impacting 15% of product quality assurance. Market concentration, with the top 10 players controlling 70%, leaves smaller companies struggling for market share. Regulatory fragmentation across North America, Europe, and Asia-Pacific adds complexity, affecting 12% of cross-border operations. High energy consumption and solvent management costs influence 35% of production facilities, reducing overall profitability. Additionally, emerging markets face challenges in obtaining licenses, with 8% of facilities delayed due to legal restrictions.

Cannabis Extraction Market Segmentation

The Cannabis Extraction market is segmented based on type, application, and technology to address diverse end-user requirements. By type, supercritical CO2 extraction dominates with 48% of global adoption, while solvent-less extraction accounts for 25%, and other methods represent 27%. In terms of application, medical usage is the primary driver, contributing 55% of extraction demand, whereas recreational products account for 45%. Geographically, North America leads with 45% market share due to over 3,400 licensed extraction facilities, processing 2,100 metric tons of cannabis in 2025. Europe has 1,200 facilities, contributing 22% of the market, while Asia-Pacific is emerging rapidly with an increase from 300 facilities in 2024 to over 800 by 2030.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Solvent-less Extraction: Solvent-less extraction refers to methods of obtaining cannabinoids without using chemical solvents, relying instead on mechanical or physical processes. Techniques such as rosin pressing, ice water extraction, and dry sift contribute to 25% of global cannabis extraction methods in 2025. Over 2,000 facilities worldwide utilize solvent-less methods due to the high demand for solvent-free concentrates, particularly in North America, where 60% of users prefer clean-label products.

The Solvent-less Extraction segment of the Cannabis Extraction Market is valued at USD 1.12 billion in 2025, with a market share of 42% and a CAGR of 8.1%, driven by consumer preference for chemical-free extracts, rising awareness of health benefits, and increasing legalization for both medical and recreational uses.

Top 5 Major Dominant Countries in the Solvent-less Extraction Segment

• United States: Valued at USD 0.56 billion with a 50% share and CAGR of 8.3%, growth supported by expanding recreational cannabis legalization, rising demand for chemical-free concentrates, and increased investment in advanced extraction technologies nationwide.
• Canada: USD 0.22 billion, 20% share, CAGR 7.9%, driven by strong medical cannabis adoption, increasing production of solvent-free extracts, and government-backed cannabis industry expansion across urban and rural regions.
• Germany: USD 0.12 billion, 11% share, CAGR 7.5%, fueled by medical cannabis regulations, growing solvent-less extraction adoption, and increasing availability of high-quality extracts across healthcare and consumer markets.
• Netherlands: USD 0.10 billion, 9% share, CAGR 7.4%, growth driven by well-established recreational cannabis culture, rising solvent-free concentrate consumption, and advanced extraction technology adoption in domestic markets.
• Israel: USD 0.08 billion, 7% share, CAGR 7.2%, supported by medical cannabis research initiatives, solvent-less extraction production growth, and rising consumer awareness of safer and chemical-free extracts nationwide.

Sub/Supercritical CO2 Extraction: Sub/Supercritical CO2 extraction is the most widely adopted technique in cannabis extraction, representing 48% of global operations. In 2025, over 3,900 facilities worldwide use this method due to its efficiency, high purity, and environmental safety. North America accounts for 55% of all CO2 extraction facilities, processing 1,800 metric tons of cannabis annually. This method allows selective extraction of cannabinoids and terpenes, producing high-potency oils for medical and recreational applications.

The Sub/Supercritical CO2 Extraction segment is valued at USD 1.54 billion in 2025, representing 58% of the market, and growing at a CAGR of 8.5%, fueled by demand for high-purity extracts, scalable industrial operations, and favorable regulatory frameworks for medical and recreational cannabis extraction.

Top 5 Major Dominant Countries in the Sub/Supercritical CO2 Extraction Segment

• United States: USD 0.78 billion, 51% share, CAGR 8.6%, growth driven by rising demand for pharmaceutical-grade cannabis extracts, advanced CO2 extraction technologies, and increasing recreational cannabis legalization in multiple states.
• Canada: USD 0.34 billion, 22% share, CAGR 8.3%, supported by expanding medical cannabis adoption, industrial-scale CO2 extraction facilities, and government-supported initiatives to promote solvent-free production techniques.
• Germany: USD 0.16 billion, 10% share, CAGR 8.0%, fueled by robust medical cannabis programs, rising CO2 extract usage, and strong healthcare demand for pure cannabinoid concentrates nationwide.
• Netherlands: USD 0.15 billion, 9% share, CAGR 7.8%, driven by solvent-free extract demand in recreational markets, technological advancements in extraction systems, and well-established cannabis consumer culture.
• Israel: USD 0.11 billion, 7% share, CAGR 7.6%, supported by medical research initiatives, increasing CO2 extraction adoption, and regulatory support for pharmaceutical-quality cannabis production and export.

BY APPLICATION

Recreational: Recreational cannabis extraction accounts for 45% of the global market, with North America leading at 60% of total recreational extract consumption. In 2025, over 1,260 metric tons of cannabis were processed for recreational products in the USA alone, primarily in California, Colorado, and Oregon. Popular extracts include concentrates, oils, vape cartridges, and edibles, with supercritical CO2 extraction used in 50% of operations and solvent-less methods in 30%. Europe contributed 20% of recreational extraction volume, with Germany and the Netherlands as leaders, while Asia-Pacific is emerging with 12% market share due to legalization in Thailand and Australia.

The Recreational application segment is valued at USD 1.48 billion, holding 56% of the market, with a CAGR of 8.2%, driven by legalization trends, growing public acceptance, and rising demand for solvent-free and high-quality cannabis extracts for personal and leisure use.

Top 5 Major Dominant Countries in the Recreational Application

• United States: USD 0.75 billion, 51% share, CAGR 8.3%, growth supported by expanding recreational legalization, rising demand for chemical-free extracts, and increasing domestic production of high-quality concentrates nationwide.
• Canada: USD 0.32 billion, 22% share, CAGR 8.1%, fueled by legalized recreational use, growth in solvent-less extract consumption, and rising consumer interest in high-quality and safe cannabis products.
• Netherlands: USD 0.14 billion, 10% share, CAGR 7.9%, driven by well-established recreational cannabis culture, adoption of solvent-less and CO2 extracts, and demand for premium concentrates in urban markets.
• Germany: USD 0.12 billion, 8% share, CAGR 7.7%, supported by recreational pilot programs, rising extract consumption, and advanced extraction technologies enabling higher purity products.
• Uruguay: USD 0.08 billion, 5% share, CAGR 7.5%, fueled by government-backed recreational cannabis programs, growing public acceptance, and increased availability of safe, high-quality extracts nationwide.

Medical: Medical cannabis extraction dominates 55% of global market demand, driven by growing prescriptions for cannabinoids in pain management, epilepsy, multiple sclerosis, and cancer therapies. In North America, over 1,050 metric tons of cannabis were processed for medical applications in 2025, with 65% using CO2 extraction methods to ensure high-purity isolates. Europe contributed 22% of medical extraction output, while Asia-Pacific is rapidly expanding from 300 facilities in 2024 to 800 by 2030 due to increasing legalization for therapeutic use. Key products include cannabinoid oils, capsules, tinctures, and topical.

The Medical application segment is valued at USD 1.18 billion, representing 44% of the market, growing at a CAGR of 8.4%, supported by rising patient adoption, clinical research, and demand for precise, high-purity extracts in pharmaceutical and therapeutic applications.

Top 5 Major Dominant Countries in the Medical Application

• United States: USD 0.60 billion, 51% share, CAGR 8.5%, growth driven by increasing medical cannabis patient numbers, adoption of CO2 and solvent-less extraction methods, and availability of high-purity pharmaceutical-grade extracts.
• Canada: USD 0.28 billion, 24% share, CAGR 8.2%, supported by government medical cannabis programs, high-quality extraction standards, and growing patient demand for solvent-free concentrates nationwide.
• Germany: USD 0.15 billion, 13% share, CAGR 8.0%, fueled by medical cannabis prescriptions, adoption of high-purity extraction technologies, and strong healthcare industry support for safe cannabis products.
• Israel: USD 0.10 billion, 8% share, CAGR 7.8%, growth driven by medical research initiatives, pharmaceutical-grade extract production, and government support for patient access to high-quality cannabis concentrates.
• Australia: USD 0.05 billion, 4% share, CAGR 7.6%, supported by medical cannabis programs, increasing solvent-free extract adoption, and growing therapeutic use for patient healthcare requirements.

Regional Outlook of the Cannabis Extraction Market

The global cannabis extraction market is heavily dominated by North America, followed by Europe and Asia-Pacific, while the Middle East & Africa are gradually emerging. In 2025, North America held 45% of global extraction facilities, processing 2,100 metric tons of cannabis, largely due to legalization in the USA and Canada. Europe contributed 22% of global capacity, with Germany, the Netherlands, and Switzerland leading in both recreational and medical extractions. Asia-Pacific is growing rapidly, increasing from 300 licensed facilities in 2024 to over 800 by 2030, supported by regulatory relaxations in Thailand, South Korea, and Australia.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America remains the largest market, with over 3,400 licensed extraction facilities in 2025, accounting for 45% of global operations. The USA processes 2,100 metric tons of cannabis annually, with California alone contributing 1,800 metric tons. CO2 extraction represents 48% of technology adoption, and solvent-less methods cover 25%. The region is also witnessing an increase in automated extraction systems, with over 500 new units projected by 2030. Recreational products contribute 30% of market demand, while medical applications dominate at 55%.

The North America Cannabis Extraction market is valued at USD 2.38 billion in 2025, with a CAGR of 8.4%, driven by legalization, rising recreational and medical cannabis adoption, and growing investment in advanced solvent-less and CO2 extraction technologies in the United States, Canada, and Mexico.

North America - Major Dominant Countries in the Cannabis Extraction Market

• United States: USD 1.34 billion, 56% share, CAGR 8.5%, growth supported by federal and state-level legalization, rising recreational and medical cannabis adoption, and large-scale industrial extraction facilities using solvent-free and CO2 techniques.
• Canada: USD 0.60 billion, 25% share, CAGR 8.2%, fueled by nationwide medical and recreational cannabis legalization, growth in CO2 extraction plants, and increasing patient and consumer adoption of high-purity extracts.
• Mexico: USD 0.21 billion, 9% share, CAGR 7.9%, driven by emerging recreational cannabis frameworks, growing solvent-less extract consumption, and investment in modern extraction technologies across key urban areas.
• Puerto Rico: USD 0.13 billion, 5% share, CAGR 7.7%, supported by local medical cannabis programs, increasing patient access, and adoption of CO2 and solvent-less extraction methods nationwide.
• Jamaica: USD 0.10 billion, 5% share, CAGR 7.6%, fueled by recreational cannabis use growth, solvent-free extract adoption, and government initiatives supporting small-scale extraction operations.

EUROPE

Europe held 22% of global extraction facilities in 2025, with Germany, the Netherlands, and Switzerland leading production. Over 1,200 extraction units were operational, processing 650 metric tons of cannabis for medical and recreational use. CO2 extraction accounts for 42%, and solvent-less methods 28%. Countries like the UK and Spain are emerging in medical cannabis extraction, contributing 12% of regional growth, while research in pharmaceutical cannabinoids drives innovation in high-purity extracts.

The Europe Cannabis Extraction market is valued at USD 1.25 billion, with a CAGR of 7.9%, supported by increasing medical cannabis adoption, regulatory approvals for solvent-less and CO2 extracts, and growth in pharmaceutical-grade production in Germany, Netherlands, Italy, Spain, and the UK.

Europe - Major Dominant Countries in the Cannabis Extraction Market

• Germany: USD 0.42 billion, 34% share, CAGR 8.0%, fueled by medical cannabis programs, patient adoption growth, and expansion of CO2 extraction facilities producing high-purity extracts nationwide.
• Netherlands: USD 0.32 billion, 26% share, CAGR 7.8%, driven by recreational and medicinal cannabis culture, growth in solvent-less extraction, and rising industrial-scale production for export and domestic use.
• Italy: USD 0.18 billion, 14% share, CAGR 7.7%, supported by medical cannabis frameworks, adoption of CO2 extraction technologies, and increasing domestic pharmaceutical demand for safe extracts.
• Spain: USD 0.16 billion, 13% share, CAGR 7.6%, growth driven by recreational cannabis clubs, rising solvent-less extract consumption, and investment in advanced extraction systems across urban centers.
• UK: USD 0.17 billion, 13% share, CAGR 7.5%, fueled by medical cannabis program expansion, growth of pharmaceutical-grade extract production, and increasing patient access to high-quality cannabis concentrates nationwide.

ASIA-PACIFIC

Asia-Pacific is rapidly expanding, increasing from 300 facilities in 2024 to over 800 by 2030. Thailand, South Korea, and Australia lead with 65% of regional extraction activities. Supercritical CO2 extraction accounts for 38% of operations, while solvent-less methods represent 20%. The market growth is fueled by legalization of medical cannabis, rising pharmaceutical collaborations, and growing consumer awareness of therapeutic cannabinoids. Regional demand for extracts in edibles and cosmetics is projected to increase by 30% by 2030.

The Asia Cannabis Extraction market is valued at USD 0.78 billion, with a CAGR of 7.5%, supported by emerging medical cannabis legalization, increasing industrial adoption of CO2 extraction technologies, and growing demand for high-purity extracts in China, Israel, India, South Korea, and Japan.

Asia - Major Dominant Countries in the Cannabis Extraction Market

• Israel: USD 0.30 billion, 38% share, CAGR 7.7%, driven by research-based medical cannabis adoption, advanced CO2 extraction facilities, and growing pharmaceutical and patient demand for pure solvent-free extracts nationwide.
• China: USD 0.18 billion, 23% share, CAGR 7.5%, fueled by medical cannabis pilot programs, investment in industrial CO2 extraction technology, and rising demand for pharmaceutical-grade extracts.
• India: USD 0.12 billion, 15% share, CAGR 7.3%, supported by emerging medical cannabis frameworks, growing adoption of solvent-less extract technologies, and patient access expansion in urban areas.
• South Korea: USD 0.10 billion, 13% share, CAGR 7.2%, growth driven by medical cannabis research initiatives, pharmaceutical-grade extraction expansion, and increasing government support for high-quality cannabis products.

• Japan: USD 0.08 billion, 11% share, CAGR 7.1%, fueled by pharmaceutical research, patient adoption of CO2 extracts, and industrial-scale extraction technology development across major cities.

MIDDLE EAST & AFRICA

Middle East & Africa account for 8% of the global cannabis extraction market. South Africa and Israel dominate regional production, with over 50 licensed extraction facilities in 2025. CO2 extraction constitutes 35% of regional operations, while solvent-less methods account for 18%. The market is primarily driven by medical cannabis programs, research initiatives, and increasing investment in controlled cultivation. By 2030, the region is expected to add 70 new facilities, boosting market volume by 12%.

The Middle East and Africa Cannabis Extraction market is valued at USD 0.52 billion, with a CAGR of 7.4%, driven by medical cannabis adoption, government support for pharmaceutical extract production, and rising awareness of solvent-free and CO2 extraction technologies across UAE, South Africa, Egypt, Saudi Arabia, and Morocco.

Middle East and Africa - Major Dominant Countries in the Cannabis Extraction Market

• UAE: USD 0.18 billion, 35% share, CAGR 7.6%, supported by medical cannabis program expansion, adoption of high-purity CO2 extraction methods, and rising demand for pharmaceutical-grade extracts nationwide.
• South Africa: USD 0.14 billion, 27% share, CAGR 7.5%, fueled by cannabis legalization initiatives, industrial-scale solvent-less extraction growth, and increasing domestic pharmaceutical and therapeutic adoption.
• Egypt: USD 0.08 billion, 15% share, CAGR 7.3%, driven by medical cannabis program adoption, growth of CO2 extraction facilities, and rising patient and pharmaceutical demand across key urban regions.
• Saudi Arabia: USD 0.07 billion, 13% share, CAGR 7.2%, supported by regulated pharmaceutical cannabis production, CO2 extract adoption, and industrial investment in advanced extraction technologies nationwide.
• Morocco: USD 0.05 billion, 10% share, CAGR 7.1%, fueled by medicinal cannabis pilot initiatives, adoption of solvent-less and CO2 extraction methods, and increasing pharmaceutical-grade extract production in key regions.

List of Top Cannabis Extraction Companies

• Curaleaf
• MedMen
• Columbia Care
• Halo
• Harvest House of Cannabis
• Acreage Holdings
• Planet 13
• Trulieve
• Cresco Labs
• Green Thumb Industries

Curaleaf: Curaleaf operates 130 facilities in the U.S., producing 600 metric tons of cannabis annually. The company specializes in CO2 and hybrid extraction methods, with 65% of output dedicated to medical applications. Curaleaf also invests in automation and high-purity concentrate production, maintaining a 20% market share in North America.

MedMen: MedMen has 80 extraction and retail facilities, processing 350 metric tons annually. The company focuses on both recreational and medical cannabis extracts, with 50% of production utilizing solvent-less extraction. MedMen has expanded into innovative product lines, including terpene-infused concentrates and premium oils for pharmaceutical applications.

Investment Analysis and Opportunities

The cannabis extraction market presents significant investment opportunities due to expanding medical and recreational demand. North America processed 2,100 metric tons of cannabis in 2025, representing 45% of global production, while Europe accounted for 22%. Emerging markets in Asia-Pacific and the Middle East are projected to add 1,000 new extraction facilities by 2030. Investment in automated CO2 extraction units is increasing, with over 500 planned installations globally. Pharmaceutical collaborations and R&D initiatives cover 20% of total market activities, creating high-value opportunities for investors. Market opportunities also exist in functional foods, cosmetics, and nutraceuticals, with 35% of extracted cannabinoids allocated for these applications. Expansion of hybrid solvent technologies and ultrasonic-assisted methods is expected to improve yields by 15-20%, increasing profitability for new entrants.

New Product Development

Cannabis extraction companies are focusing on high-purity cannabinoids for medical, recreational, and cosmetic applications. In 2025, over 1,050 metric tons of medical cannabis were processed in North America, while Europe produced 650 metric tons. Companies are investing in novel extraction techniques, including hybrid solvent and ultrasonic-assisted systems, adopted by 12% of global facilities. New products such as terpene-rich oils, cannabinoid-infused edibles, functional beverages, and topicals now account for 35% of global extract consumption. Product innovation is particularly strong in the USA and Europe, with over 500 new formulations introduced in 2025. These developments enhance consumer choice and open new revenue streams for investors targeting premium cannabis extracts.

Five Recent Developments

• Over 500 new CO2 extraction units launched globally in 2025, increasing production capacity by 15%.
• Thailand legalized medical cannabis extraction in 2024, adding 120 new facilities in Asia-Pacific.
• Curaleaf expanded operations to process an additional 200 metric tons annually in 2025.
• MedMen introduced solvent-less terpene-rich concentrates, contributing 18% of its product portfolio.
• Europe saw a 22% increase in licensed extraction facilities between 2024 and 2025, driven by Germany and Netherlands.

Report Coverage of Cannabis Extraction Market

The report covers global cannabis extraction market trends, technology adoption, and competitive landscape. Between 2024 and 2033, global extraction facilities are projected to increase from 7,500 to over 12,000. North America leads with 45% of capacity, while Europe contributes 22%, and Asia-Pacific grows from 300 to 800 facilities. Key topics include extraction type segmentation, application analysis, and regional market insights. The report also highlights investment opportunities in automation, hybrid extraction methods, and emerging high-value products. Additionally, over 1,050 metric tons of medical cannabis were processed in North America in 2025, while recreational extracts accounted for 1,260 metric tons.

Cannabis Extraction Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 4865.79 Million in 2026
Market Size Value By	USD 26594.04 Million by 2035
Growth Rate	CAGR of 20.77% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Solvent-less Extraction Sub/Supercritical CO2 Extraction Ethanol Extraction Hydrocarbon Extraction Others By Application : Recreational Medical
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample